Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis

NCT00173264 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2005-09-15

No results posted yet for this study

Summary

The purpose of this study is to determine whether the monoclonal protein in patients with tuberculosis and monoclonal gammopathy has anti-tuberculous activity, and whether genes coding their monoclonal proteins show characteristic mutations.

Conditions

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • LINA LEE, MD,PhD · Department of labrotoary medicine,National Taiwan University Hospital

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Completion
2005-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00173264 on ClinicalTrials.gov